CliffBio

Tersera Therapeutics

Patent cliffs & loss of exclusivity

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VARUBIROLAPITANT HYDROCHLORIDESmall mol.Oct 2029
  2. QMIIZ ODTMELOXICAMSmall mol.Aug 2030
  3. QMIIZ ODTMELOXICAMSmall mol.Aug 2030
  4. XERMELOTELOTRISTAT ETIPRATESmall mol.Feb 2031
  5. VARUBIROLAPITANT HYDROCHLORIDESmall mol.Jul 2032
  6. ZOLADEXGOSERELIN ACETATESmall mol.—
  7. ZOLADEXGOSERELIN ACETATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.